Drugs Information: Repaglinide
Basic Information
|
||
| ID | DDInter1581 | |
| Drug Type | small molecule | |
| Molecular Formula | C27H36N2O4 | |
| Molecular Weight | 452.595 | |
| Description | Repaglinide is a antihyperglycemic used to improve glycemic control in diabetes. | |
| ATC Classification | A10BD14 A10BX02 | |
| IUPAC Name | 2-Ethoxy-4-({[(1S)-3-Methyl-1-[2-(Piperidin-1-Yl)Phenyl]Butyl]Carbamoyl}Methyl)Benzoic Acid | |
| InChI | Inchi=1S/C27H36N2O4/C1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/H6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/T23-/M0/S1 | |
| InChI Key | FAEKWTJYAYMJKF-QHCPKHFHSA-N | |
| Canonical SMILES | CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1)C(O)=O | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Repaglinide
| Severity level | ID | Name | Mechanism | Detail |
|---|